Semaglutide treatment,
online and simplified.

No. GLP-1 (glucagon-like peptide-1) is a natural hormone your body produces that regulates appetite and blood sugar. It is the biological pathway — the category. Semaglutide is a medication name — a specific drug that mimics GLP-1 by binding to the same receptors. Think of GLP-1 as the system and semaglutide as one tool that activates it.

No, they are different medications with different mechanisms. Semaglutide activates GLP-1 receptors only (single agonist). Tirzepatide activates both GLP-1 and GIP receptors (dual agonist). This dual-receptor action is the key difference and may contribute to different average weight loss outcomes observed in clinical studies. Both require a licensed provider to determine if either is medically appropriate for you.

No. Surfbound offers both oral and injectable GLP-1 treatment options. Injectable treatments are typically once-weekly subcutaneous injections using a small, fine needle. Oral options are daily pills with no needles involved. Your provider will discuss which administration route, if any, is medically appropriate for your situation.

No — and you should not have to. The medication decision is made by a licensed provider based on a review of your complete health profile, including medical history, current medications, BMI, allergies, and treatment goals. You complete the intake describing your situation and goals. The provider determines what, if anything, is medically appropriate. You do not need to research or decide between medications before starting.

Provider review is typically completed within 24 hours of intake submission, though timing can vary based on case volume and complexity. Most patients hear back within one business day. If the provider needs additional information — for example, clarification about your health history or current medications — they will contact you through the secure platform, which may extend the timeline slightly.

No. A prescription is never guaranteed. An independent licensed provider reviews your health profile and makes a clinical determination based on medical criteria. Some people do not qualify for GLP-1 treatment due to specific medical conditions, medication interactions, or other health factors. Nothing is charged unless your medication is approved.

No. Compounded medications, including compounded semaglutide and tirzepatide, are not FDA-approved finished drug products. The FDA does not review compounded preparations for safety, effectiveness, or quality before they reach patients. They are prepared by licensed compounding pharmacies for individual patients when a provider determines there is a valid clinical reason. Compounded medications are prepared by licensed compounding pharmacies pursuant to applicable law and individual prescriptions when appropriate. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Compounded preparations are not manufactured by brand-name pharmaceutical companies and are not affiliated with them.

Semaglutide treatment through Surfbound is $169 per month with no insurance required. There are no membership fees, no hidden charges, and no long-term commitments. You pay for your treatment on a monthly basis. Your provider review is included. Start with the online intake — the provider determines if treatment is appropriate. Nothing is charged unless your medication is approved. Once treatment is approved, payment becomes nonrefundable because prescription and pharmacy processing begin.

Yes. Prescribed GLP-1 medications — including compounded formulations — are generally eligible for HSA and FSA reimbursement as qualified medical expenses. You may need a Letter of Medical Necessity from your provider for some FSA plans. Keep your pharmacy receipts and prescription documentation. Check with your plan administrator for specific requirements.

No. Surfbound does not charge separate membership fees or hidden charges. You pay for your treatment on a per-month basis with no long-term commitment. The provider review is included in the program cost. Cancel anytime directly inside your patient portal. Pricing is shown transparently before you complete the intake.

Most people notice appetite changes within the first few days to two weeks. Measurable weight loss typically becomes apparent after 4-8 weeks of consistent use. The medication starts at a low dose and gradually increases over several weeks to months — significant weight loss accumulates over time, not overnight. In clinical studies, participants reached their maximum weight loss around 12-16 months of consistent treatment.

After you submit your intake, a licensed provider reviews your health history, current medications, BMI, allergies, and treatment goals — typically within 24 hours, though timing can vary. The provider determines whether GLP-1 treatment is medically appropriate for you. If prescribed, the prescription is sent to a licensed pharmacy partner, and your medication ships discreetly. Nothing is charged unless your medication is approved.

After provider approval and pharmacy processing, medication typically ships promptly in temperature-controlled packaging. Many orders ship within approximately 1–2 days after pharmacy processing, although timing may vary by pharmacy, patient location, weekends, and holidays. Tracking is provided. Medication is shipped in discreet, temperature-controlled packaging.

Compounded semaglutide is prepared by licensed compounding pharmacies for individual patients. It is not an FDA-approved finished drug product. The FDA does not review compounded medications for safety, effectiveness, or quality before they reach patients. Compounded semaglutide is not a generic equivalent of any FDA-approved product, has not been compared to FDA-approved products in clinical trials, and is not manufactured by or affiliated with any brand-name pharmaceutical company. Compounded medications may be prescribed for an individual patient when clinically appropriate and permitted under applicable law. Your provider can discuss whether this option may be appropriate for your situation.

If you are currently taking any GLP-1 medication and are considering a change — whether for cost, availability, or other reasons — current-dose matching is available when you switch to Surfbound. At the end of sign-up, add your current medication and prescribed dose in the doctor-notes field, and tell the provider whether you want to keep your current dose or discuss progressing. A licensed provider confirms the prescription and any dose change. Do not change or stop any medication without provider guidance.

Both are semaglutide-based medications — but they differ significantly in how they are taken and how they work in the body. Oral semaglutide is a daily pill absorbed through the digestive tract. Injectable semaglutide is a once-weekly subcutaneous injection that enters the bloodstream directly through fatty tissue. The absorption pathways are different, the dosing schedules are different, and the practical experience for the patient is different. Both require a prescription and licensed provider review. Your provider determines which route, if any, is medically appropriate for your situation.

There is no universal better option. The choice between oral and injectable semaglutide depends on your individual health profile, lifestyle, preferences, and what your provider determines is medically appropriate. Some people prefer the familiarity of a daily pill and the absence of needles. Others prefer the once-weekly routine of an injection and do not mind the supplies involved. Injectable semaglutide, in its FDA-approved form, has more extensive clinical trial data for weight loss. Oral semaglutide, in its FDA-approved form, is indicated for type 2 diabetes, and compounded oral versions have not been studied in the same way. Your Surfbound provider will discuss the trade-offs with you during the review process.

GLP-1 medications follow a gradual dose escalation called titration. Treatment typically begins at a low starting dose — not the full therapeutic dose — and increases every 4 weeks based on your response and tolerability. This slow increase gives your body time to adapt and reduces the likelihood of gastrointestinal side effects. Your provider determines your specific starting dose and titration schedule based on your health profile. Never increase your dose faster than prescribed.

Yes. There are no long-term commitments or contracts. Plans renew monthly until canceled. Cancel directly inside your patient portal at any time before your next renewal. There is no cancellation fee or required notice period. Once medication for the current month has been ordered from the pharmacy, that month is non-refundable. If you stop treatment, you can restart later with a new intake and provider review.

Yes. GLP-1 medications can be traveled with. Keep medication in your carry-on luggage — never in checked bags. TSA permits medically necessary injectable medications and supplies. Carry your medication in its original pharmacy-labeled packaging if possible. Most formulations are stable at room temperature for a limited period, so short trips may not require refrigeration. For longer trips, use an insulated medication cooler. If crossing time zones, taking your dose a few hours earlier or later than usual is acceptable.

Follow the instructions provided with your specific prescription. If you are unsure what to do after a missed dose, contact your prescribing provider or dispensing pharmacy before changing your dosing schedule. Never take two doses close together. If you miss multiple doses, contact your provider for guidance on safely restarting.